2-Methyl-4H-thieno[3,2-b]pyrrole-5-carboxylic acid, 95.0%, 5g

METHYL 4-BROMOISOQUINOLINE-1-CARBOXYLATE, 97.0%, 250mg

(R)-2-Methoxy-2-(naphthalen-1-yl)propanoic acid, 95.0%, 2g

3-(5-Fluoro-2-methoxyphenyl)-1-propene, 97.0%, 2g

(2R,6R)-1,2,6-trimethylpiperazine dihydrochloride, 97.0%, 1g

5-Methylamino-pentanoic acid; hydrochloride, 95.0%, 1g

2-Azido-1,3-bis[(2,2-dimethyl-1,3-dioxan-5-yl)oxy]propane>95.0%(HPLC)100mg

1-(3-(Trifluoromethyl)pyridin-2-yl)cyclopropane-1-carbonitrile, 98%, 500mg

1-[1-methyl-5-(trifluoromethyl)-1H-1,3-benzodiazol-2-yl]methanamine dihydrochloride, 95.0%, 250mg

DL-Aspartic Acid, min. 98%, for biochemistry, 25 g, plastic packaging.

(3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one, 98%, 100g

4-Fluoro-1-nitro-2-(trifluoromethoxy)benzene, 95%, 5g

6,6',6'',6'''-(Pyrene-1,3,6,8-tetrayl)tetrakis(2-naphthoic acid), 97%, 25g